Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Creative Life Science Co's revenue for the
six
months ended in Jun. 2026 was NT$567 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was NT$1,162 Mil.
Creative Life Science Co's Revenue per Share for the
six
months ended in Jun. 2026 was NT$24.87.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was NT$51.47.
Warning Sign:
Creative Life Science Co Ltd revenue per share has been in decline over the past 3 years.
During the past 5 years, Creative Life Science Co's highest 3-Year average Revenue per Share Growth Rate was -6.90% per year. The lowest was -6.90% per year. And the median was -6.90% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Creative Life Science Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creative Life Science Co Revenue vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Creative Life Science Co's Revenue distribution charts can be found below:
* The bar in red indicates where Creative Life Science Co's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$1,162 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creative Life Science Co (ROCO:7837) has a Revenue of NT$1,162 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Creative Life Science Co and its competitors.
Is Creative Life Science Co's Revenue too high?
Creative Life Science Co's current Revenue is NT$1,162 Mil. Overall, Creative Life Science Co has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Creative Life Science Co's Revenue compare to VRTX and REGN?
Creative Life Science Co's Revenue of NT$1,162 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Biotechnology company?
A good Revenue depends on the Biotechnology industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Creative Life Science Co and its competitors. Creative Life Science Co's current Revenue is NT$1,162 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creative Life Science Co stock overvalued right now?
Creative Life Science Co (ROCO:7837) has a current Revenue of NT$1,162 Mil. The current Revenue is NT$1,162 Mil. Creative Life Science Co's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Creative Life Science Co (ROCO:7837), the current Revenue is NT$1,162 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Creative Life Science Co Ltd is engaged in providing products of microbiology, and it has prepared media products and diagnostic reagents. The main products of CMP (Creative Media Plate) are solid and liquid media, which can be used for clinical microbiology, basic microbial research, environmental monitoring, biosafety testing, and quality control. Its product line is Transport Medium, Prepared Tube Media, Prepared Plated Media, VTM & I-VTM, Bacterial strain preservation system, and CMP SteriPack triple wrapped media.
29GF Score
Get the complete analysis for ROCO:7837
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7837 has been successfully added to your 
